Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for regenerative medicine
3.2.1.2 Rising incidence of chronic wounds
3.2.1.3 Advancements in biotechnology and tissue engineering
3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited shelf life of amniotic membrane products
3.2.2.2 Stringent regulatory polices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Cryopreserved
5.3 Lyophilized
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Surgical wounds
6.3 Ophthalmology
6.4 Stem cell biology
6.5 Regenerative medicine
6.6 Prenatal diagnosis
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers (ASCs)
7.4 Specialty clinics
7.5 Research and academic institutes
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Alliqua BioMedical Inc.
9.2 Alynx, Co.
9.3 Amnio Technology, LLC
9.4 Applied Biologics LLC
9.5 BioTissue Holdings Inc.
9.6 Corza Health, Inc.
9.7 Integra LifeSciences Corporation
9.8 Organogensis, Inc.
9.9 Skye Biologics, Inc.
9.10 TissueTech, Inc.
